Expensify Inc vs Figs Inc — how do they compare? Expensify Inc trades at $2.43 (market cap $208.82M), while Figs Inc trades at $15.29 (market cap $2.49B). The key difference: Figs Inc is far larger — about 11.9× Expensify Inc's market cap, and Expensify Inc is more actively traded (456,102 versus 5,964,311). Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Figs Inc for 33 Days on average.
| EXFY | FIGS | |
|---|---|---|
Market Cap | $208.82M | $2.49B |
Volume | 456,102 | 5,964,311 |
Sector | Technology | Consumer Cyclical |
52-Week High | $2.72 | $17.12 |
52-Week Low | $0.75 | $6.90 |
Typical Hold Time | 41 Days | 33 Days |
Enterprise Value | $148.44M | $2.25B |
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.37, up 4.41% with a neutral technical signal despite bullish moving averages. The company shows mixed fundamentals with a high P/E ratio of 258.82 but improving cash flow trends, with Q2 2026 earnings beating expectations. Recent news highlights strategic integrations with AI-native ERP platforms and European expansion of its corporate card offering, signaling growth initiatives.
The outlook remains speculative with analyst consensus bullish (50% buy ratings) and a $13.75 price target, but negative net income margins and competitive pressures pose risks. Investment opportunity hinges on successful execution of AI-driven products and international growth, while downside risks include sustained profitability challenges and market volatility.
FIGS trades at $14.06, down 0.28% on the day, with a bullish technical signal supported by moving averages. The company shows strong revenue growth with 2025 revenue reaching $631.10M and net income of $34.25M, representing a 5.42% margin. Recent earnings beats and raised 2026 guidance indicate positive momentum, though valuation ratios remain elevated with a P/E of 45.39 and P/S of 4.02.
Wall Street maintains a bullish stance with 60% buy ratings and a $18.00 consensus price target, suggesting 28% upside potential. Key risks include execution challenges in international expansion and rich valuation multiples that require continued strong performance. The company's expanding customer base and international growth provide catalysts for future appreciation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →